ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

Comprehensive Genomic Profiling With Loss of Heterozygosity for Ovarian Cancer Treatment

Julia Elvin, MD, PhD
Published Online:6:07 PM, Fri June 16, 2017

Julia Elvin, MD, PhD, vice president and senior associate medical director, Foundation Medicine, discusses a study of comprehensive genomic profiling with loss of heterozygosity to identify therapeutically relevant subsets of ovarian cancer.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.